Gabelle Audrey, Gutierrez Laure-Anne, Jaussent Isabelle, Ben Bouallegue Fayçal, De Verbizier Delphine, Navucet Sophie, Grasselli Caroline, Bennys Karim, Marelli Cécilia, David Renaud, Mariano-Goulart Denis, Andrieu Sandrine, Vellas Bruno, Payoux Pierre, Berr Claudine, Dauvilliers Yves
Department of Neurology, Memory Research and Resources Center, CHU Montpellier, Montpellier, France.
INSERM, U1061, Neuropsychiatrie, Recherche Clinique et Epidémiologique, Montpellier, France.
Front Neurol. 2019 Sep 13;10:989. doi: 10.3389/fneur.2019.00989. eCollection 2019.
To determine the relationships between self-reported sleep profile and cortical amyloid load in elderly subjects without dementia. This cross-sectional study included 143 community-dwelling participants aged ≥70 years (median: 73 years [70-85]; 87 females) with spontaneous memory complaints but dementia-free. Sociodemographic characteristics, health status, neuropsychological tests, sleep, and F-florbetapir (amyloid) PET data were collected. The clinical sleep interview evaluated nighttime sleep duration, but also daytime sleep duration, presence of naps, and restless leg syndrome (RLS) at time of study. Validated questionnaires assessed daytime sleepiness, insomnia, and risk of sleep apnea. The cortical standardized uptake value ratio (SUVr) was computed across six cortical regions. The relationship between sleep parameters and SUVr (cut-off ratio>1.17 and tertiles) was analyzed using logistic regression models. Amyloid-PET was positive in 40.6% of participants. Almost 40% were at risk for apnea, 13.5% had RLS, 35.5% insomnia symptoms, 22.1% daytime sleepiness, and 18.8% took sleep drugs. No significant relationship was found between positive amyloid PET and nighttime sleep duration (as a continuous variable, or categorized into <6; 6-7; ≥7 h per night). Logistic regression models did not show any association between SUVr and daytime sleep duration, 24-h sleep duration, naps, RLS, daytime sleepiness, insomnia symptoms, and sleep apnea risk (before and after adjustment for APOEε4 and depressive symptoms). Our study did not confirm the association between amyloid-PET burden, poor sleep quantity/quality in elderly population, suggesting that the interplay between sleep, and amyloid is more complex than described.
确定无痴呆老年受试者自我报告的睡眠状况与皮质淀粉样蛋白负荷之间的关系。这项横断面研究纳入了143名年龄≥70岁(中位数:73岁[70 - 85岁];87名女性)、有自发记忆问题但无痴呆的社区居住参与者。收集了社会人口学特征、健康状况、神经心理学测试、睡眠及氟代脱氧葡萄糖(淀粉样蛋白)PET数据。临床睡眠访谈评估夜间睡眠时间,也评估白天睡眠时间、午睡情况以及研究时的不宁腿综合征(RLS)。经过验证的问卷评估白天嗜睡、失眠及睡眠呼吸暂停风险。计算六个皮质区域的皮质标准化摄取值比率(SUVr)。使用逻辑回归模型分析睡眠参数与SUVr(截断比率>1.17及三分位数)之间的关系。40.6%的参与者淀粉样蛋白PET呈阳性。近40%有呼吸暂停风险,13.5%有RLS,35.5%有失眠症状,22.1%有白天嗜睡,18.8%服用助眠药物。淀粉样蛋白PET阳性与夜间睡眠时间(作为连续变量,或分为<6;6 - 7;≥7小时/晚)之间未发现显著关系。逻辑回归模型未显示SUVr与白天睡眠时间、24小时睡眠时间、午睡、RLS、白天嗜睡、失眠症状及睡眠呼吸暂停风险之间存在任何关联(在对APOEε4和抑郁症状进行调整前后)。我们的研究未证实老年人群中淀粉样蛋白PET负荷与睡眠数量/质量差之间的关联,提示睡眠与淀粉样蛋白之间的相互作用比所描述的更为复杂。